September 20, 2026 03:00 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Arvind Kejriwal, family ‘missing’ from Delhi voter list, claims Aam Aadmi Party | ‘No UPI above ₹2,000?’ Ghaziabad traders put up ‘cash only’ hoardings | Trump signs Russia sanctions bill: India faces fresh 100% tariff threat over Moscow oil | Caught using ChatGPT for exam answers, IIT Bombay student dies by suicide; students protest | Congress' Nandigram candidate arrested after Mamata's support amid TMC symbol row; Bengal bypoll gets chaotic | Gurugram murder shocker: Groom-to-be leaves sisters at Delhi restaurant to meet ex-colleague, found dead days later | Delhi horror: Teen allegedly gangraped, stabbed to death and dumped in field; dogs eat parts of body | TMC name, symbol frozen: EC tells rival factions to pick new identities ahead of Bengal bypolls | Married just 17 days ago: Hyderabad engineer mysteriously found dead at US home | ‘We will promote cash’: New UPI charge triggers trader backlash, Opposition protests
Serum Institute
PIB

Had a good interaction with team: Indian PM Narendra Modi tweets after visiting Serum Institute of India

| @indiablooms | Nov 29, 2020, at 12:38 am

Pune: Indian PM Narendra Modi on Saturday visited Pune's Serum Institute of India, which is working on the coronavirus vaccine, and interacted with the team at the Institute.

"They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing," read a government statement.

In a tweet, the Prime Minister said, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."  

The institute's CEO Adar Poonawala thannked PM and tweeted: "Thank you @narendramodi for visiting @SerumInstIndia . We share your vision and continue to work towards ensuring a safe and secure India."

The PM earlier in the day visited  Bharat Biotech International Limited (BBIL) at Genome Valley in Shamirpet and reviewed the progress on the manufacturing of indigenous COVID-19 vaccine 'Covaxin'.

In Ahmedabad, he reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.